Changchun High-Tech Industry (Group) Co., Ltd. (SHE:000661)

Market Cap	26.57B -30.2%
Revenue (ttm)	11.67B -12.1%
Net Income	-41.99M
EPS	-0.11
Shares Out	401.71M
PE Ratio	n/a
Forward PE	23.48
Dividend	0.16 (0.23%)
Ex-Dividend Date	May 25, 2026

Volume	4,912,852
Open	69.37
Previous Close	66.13
Day's Range	65.04 - 69.37
52-Week Range	65.38 - 141.77
Beta	0.43
Analysts	Strong Buy
Price Target	111.34 (+68.16%)
Earnings Date	Aug 14, 2026

About SHE:000661

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was foun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 10,080
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2025, SHE:000661's revenue was 12.08 billion, a decrease of -10.27% compared to the previous year's 13.47 billion. Earnings were 154.97 million, a decrease of -94.00%.